Abstract
Sphingolipids correspond to a major class of lipids which serve as indispensable structural components of membranes and play an important role in various cellular functions. They constitute ~10–20% of total membrane lipids and are known to form segregated domains in biological membranes. Sphingolipids have been shown to play a vital role in the function of various G protein-coupled receptors (GPCRs). We report here the presence of sphingolipid-binding motif (SBM) in representative GPCRs such as cholecystokinin, oxytocin and secretin receptors, and subtypes of human serotonin receptors. We previously reported the importance of sphingolipids in the function of the serotonin1A receptor, a representative member of the GPCR superfamily, involved in behavioral, cognitive, and developmental functions. In this work, we show that the serotonin1A receptor contains a putative SBM, corresponding to amino acids 205 to 213. In addition, our analysis shows that SBM is an intrinsic characteristic feature of the serotonin1A receptor and is conserved throughout the course of natural evolution. Our results represent the first report on the presence of SBM in serotonin1A receptors and provide novel insight on the molecular mechanism of GPCR-sphingolipid interaction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CRAC:
-
Cholesterol recognition/interaction amino acid consensus
- GPCR:
-
G protein-coupled receptor
- SBM:
-
Sphingolipid-binding motif
References
Alves ID, Salamon Z, Hruby VJ, Tollin G (2005) Ligand modulation of lateral segregation of a G-protein-coupled receptor into lipid microdomains in sphingomyelin/phosphatidylcholine solid-supported bilayers. Biochemistry 44:9168–9178
Ariga T, McDonald MP, Yu RK (2008) Role of ganglioside metabolism in the pathogenesis of Alzheimer’s disease-a review. J Lipid Res 49:1157–1175
Bienias K, Fiedorowicz A, Sadowska A, Prokopiuk S, Car H (2016) Regulation of sphingomyelin metabolism. Pharmacol Rep 68:570–581
Björkholm P, Ernst AM, Hacke M, Wieland F, Brügger B, von Heijne G (2014) Identification of novel sphingolipid-binding motifs in mammalian membrane proteins. Biochim Biophys Acta 1838:2066–2070
Brown RE (1998) Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. J Cell Sci 111:1–9
Chattopadhyay A (2014) GPCRs: lipid-dependent membrane receptors that act as drug targets. Adv Biol 2014:143023
Chattopadhyay A, Jafurulla M (2012) Role of membrane cholesterol in leishmanial infection. Adv Exp Med Biol 749:201–213
Chattopadhyay A, Paila YD, Shrivastava S, Tiwari S, Singh P, Fantini J (2012) Sphingolipid binding domain in the serotonin1A receptor. Adv Exp Med Biol 749:279–293
Contreras F-X, Ernst AM, Haberkant P, Björkholm P, Lindahl E, Gönen B, Tischer C, Elofsson A, von Heijne G, Thiele C, Pepperkok R, Wieland F, Brügger B (2012) Molecular recognition of a single sphingolipid species by a protein’s transmembrane domain. Nature 481:525–529
Cooke RM, Brown AJH, Marshall FH, Mason JS (2015) Structures of G protein-coupled receptors reveal new opportunities for drug discovery. Drug Discov Today 20:1355–1364
Fantini J, Barrantes FJ (2009) Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta 1788:2345–2361
Fiorino F, Severino B, Magli E, Ciano A, Caliendo G, Santagada V, Frecentese F, Perissutti E (2014) 5-HT1A receptor: an old target as a new attractive tool in drug discovery from central nervous system to cancer. J Med Chem 57:4407–4426
Haleem DJ (2015) 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson’s disease and schizophrenia. Behav Pharmacol 26:45–58
Harikumar KG, Puri V, Singh RD, Hanada K, Pagano RE, Miller LJ (2005) Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J Biol Chem 280:2176–2185
Heilker R, Wolff M, Tautermann CS, Bieler M (2009) G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov Today 14:231–240
Holthuis JCM, Pomorski T, Raggers RJ, Sprong H, van Meer G (2001) The organizing potential of sphingolipids in intracellular membrane transport. Physiol Rev 81:1689–1723
Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554
Huber T, Botelho AV, Beyer K, Brown MF (2004) Membrane model for the G-protein-coupled receptor rhodopsin: hydrophobic interface and dynamical structure. Biophys J 86:2078–2100
Jacobson K, Mouritsen OG, Anderson RGW (2007) Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9:7–14
Jacobson KA (2015) New paradigms in GPCR drug discovery. Biochem Pharmacol 98:541–555
Jafurulla M, Bandari S, Pucadyil TJ, Chattopadhyay A (2017) Sphingolipids modulate the function of human serotonin1A receptors: insights from sphingolipid-deficient cells. Biochim Biophys Acta 1859:598–604
Jafurulla M, Chattopadhyay A (2013) Membrane lipids in the function of serotonin and adrenergic receptors. Curr Med Chem 20:47–55
Jafurulla M, Chattopadhyay A (2015) Sphingolipids in the function of G protein-coupled receptors. Eur J Pharmacol 763:241–246
Jafurulla M, Pucadyil TJ, Chattopadhyay A (2008) Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors. Biochim Biophys Acta 1778:2022–2025
Jafurulla M, Tiwari S, Chattopadhyay A (2011) Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biochem Biophys Res Commun 404:569–573
Kalipatnapu S, Chattopadhyay A (2007) Membrane organization and function of the serotonin1A receptor. Cell Mol Neurobiol 27:1097–1116
Kaufman J, DeLorenzo C, Choudhury S, Parsey RV (2016) The 5-HT1A receptor in major depressive disorder. Eur Neuropsychopharmacol 26:397–410
Krogh A, Larsson B, von Heijne G, Sonnhammer ELL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567–580
Kumar GA, Jafurulla M, Chattopadhyay A (2016) The membrane as the gatekeeper of infection: cholesterol in host-pathogen interaction. Chem Phys Lipids 199:179–185
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23:2947–2948
Masserini M, Ravasi D (2001) Role of sphingolipids in the biogenesis of membrane domains. Biochim Biophys Acta 1532:149–161
Müller CP, Carey RJ, Huston JP, De Souza Silva MA (2007) Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol 81:133–178
Paila YD, Chattopadhyay A (2010) Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 51:439–466
Paila YD, Ganguly S, Chattopadhyay A (2010) Metabolic depletion of sphingolipids impairs ligand binding and signaling of human serotonin1A receptors. Biochemistry 49:2389–2397
Paila YD, Tiwari S, Chattopadhyay A (2009) Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? Biochim Biophys Acta 1788:295–302
Piccinini M, Scandroglio F, Prioni S, Buccinnà B, Loberto N, Aureli M, Chigorno V, Lupino E, DeMarco G, Lomartire A, Rinaudo MT, Sonnino S, Prinetti A (2010) Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders. Mol Neurobiol 41:314–340
Prasanna X, Jafurulla M, Sengupta D, Chattopadhyay A (2016) The ganglioside GM1 interacts with the serotonin1A receptor via the sphingolipid binding domain. Biochim Biophys Acta 1858:2818–2826
Prinetti A, Prioni S, Chiricozzi E, Schuchman EH, Chigorno V, Sonnino S (2011) Secondary alterations of sphingolipid metabolism in lysosomal storage diseases. Neurochem Res 36:1654–1668
Pucadyil TJ, Chattopadhyay A (2006) Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 45:295–333
Pucadyil TJ, Chattopadhyay A (2007) Cholesterol: a potential therapeutic target in Leishmania infection? Trends Parasitol 23:49–53
Pucadyil TJ, Kalipatnapu S, Chattopadhyay A (2005) The serotonin1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol 25:553–580
Riethmüller J, Riehle A, Grassmé H, Gulbins E (2006) Membrane rafts in host-pathogen interactions. Biochim Biophys Acta 1758:2139–2147
Rosenbaum DM, Rasmussen SGF, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459:356–363
Senes A, Gerstein M, Engelman DM (2000) Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with β-branched residues at neighboring positions. J Mol Biol 296:921–936
Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39
Simons K, van Meer G (1988) Lipid sorting in epithelial cells. Biochemistry 27:6197–6202
Singh P, Chattopadhyay A (2012) Removal of sphingomyelin headgroup inhibits the ligand binding function of hippocampal serotonin1A receptors. Biochem Biophys Res Commun 419:321–325
Singh P, Paila YD, Chattopadhyay A (2012) Role of glycosphingolipids in the function of human serotonin1A receptors. J Neurochem 123:716–724
Sjögren B, Svenningsson P (2007) Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells. Acta Physiol 190:47–53
Slotte JP (2013) Biological functions of sphingomyelins. Prog Lipid Res 52:424–437
Snook CF, Jones JA, Hannun YA (2006) Sphingolipid-binding proteins. Biochim Biophys Acta 1761:927–946
Sumiyoshi T, Park S, Jayathilake K, Roy A, Ertugrul A, Meltzer HY (2007) Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res 95:158–168
Tan SKH, Hartung H, Sharp T, Temel Y (2011) Serotonin-dependent depression in Parkinson’s disease: a role for the subthalamic nucleus. Neuropharmacology 61:387–399
van Echten-Deckert G, Herget T (2006) Sphingolipid metabolism in neural cells. Biochim Biophys Acta 1758:1978–1994
van Echten-Deckert G, Walter J (2012) Sphingolipids: critical players in Alzheimer’s disease. Prog Lipid Res 51:378–393
Vieira FS, Corrêa G, Einicker-Lamas M, Coutinho-Silva R (2010) Host-cell lipid rafts: a safe door for micro-organisms? Biol Cell 102:391–407
Wirth A, Holst K, Ponimaskin E (2017) How serotonin receptors regulate morphogenic signalling in neurons. Prog Neurobiol 151:35–56
Wu G, Lu Z-H, Kulkarni N, Ledeen RW (2012) Deficiency of ganglioside GM1 correlates with Parkinson’s disease in mice and humans. J Neurosci Res 90:1997–2008
Zeidan YH, Hannun YA (2007) Translational aspects of sphingolipid metabolism. Trends Mol Med 13:327–336
Acknowledgments
This work was supported by the Science and Engineering Research Board (Govt. of India) project (EMR/2016/002294). A.C. gratefully acknowledges J.C. Bose Fellowship from the Department of Science and Technology, Govt. of India. A.C. is an Adjunct Professor of Tata Institute of Fundamental Research (Mumbai), RMIT University (Melbourne, Australia), Indian Institute of Technology (Kanpur), and Indian Institute of Science Education and Research (Mohali). We thank members of the Chattopadhyay laboratory for critically reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Shrivastava, S., Jafurulla, M., Tiwari, S., Chattopadhyay, A. (2018). Identification of Sphingolipid-binding Motif in G Protein-coupled Receptors. In: Chattopadhyay, K., Basu, S. (eds) Biochemical and Biophysical Roles of Cell Surface Molecules. Advances in Experimental Medicine and Biology, vol 1112. Springer, Singapore. https://doi.org/10.1007/978-981-13-3065-0_10
Download citation
DOI: https://doi.org/10.1007/978-981-13-3065-0_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3064-3
Online ISBN: 978-981-13-3065-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)